Autopsy report · NCT06192004

Study of Non-Small Cell Lung Cancer Patients in the US Receiving Standard-of-Care and Initiating an Approved Therapy With Risk of Pneumonitis/ILD

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Observed event rate was below the rate required to meet study objectives.”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 month before it started.
Ran for about 1 year 4 months before it stopped.
83 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: AstraZeneca
Sponsor type: Industry
Conditions: Non-Small Cell Lung Cancer
Interventions: None (Observational Study)
Participants: 83
Sites: 23
Countries: United States

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.